参考文献/References:
[1]Cooper N,Ghanima W.Immune Thrombocytopenia[J].N Engl J Med,2019,381(10):945-955.[2]Zhao X,Zhang L,Wang J,et al.Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis[J].J Transl Med,2021,19(1):35.[3]Leavenworth JW,Wang X,Wenander CS,et al.Mobilization of natural killer cells inhibits development of collagen-induced arthritis[J].Proc Natl Acad Sci U S A,2011,108(35):14584-14589. [4]Audia S,Mahévas M,Samson M,et al.Pathogenesis of immune thrombocytopenia[J].Autoimmun Rev,2017,16(6):620-632.[5]Tian Z,Gershwin ME,Zhang C.Regulatory NK cells in autoimmune disease[J].J Autoimmun,2012,39(3):206-215.[6]范秋霞,王春美,盛光耀.NK细胞在儿童免疫性血小板减少症发病和治疗中的意义[J].中国小儿血液与肿瘤杂志,2014,19(4):210-212.[7]Moher D,Liberati A,Tetzlaff J,et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J].PLoS Med,2009,6(7):e1000097.[8]Zhang J,Zhang Q,Li Y,et al.Immune dysregulation in primary immune thrombocytopenia patients[J].Hematology,2018,23(8):510-516.[9]Zhang YJ,Qu W,Liu H,et al.Research on the negative immune regulation of NK cells in patients with primary immune thrombocytopenia[J].Chinese Journal of Hematology,2017,38(5):399-403.[10]张玉娇,瞿文,刘惠,等.免疫性血小板减少症患者NK细胞数量及功能[J].中华医学杂志,2017,97(16):1231-1235.[11]黄枝宁.特发性血小板减少性紫癜患者外周血淋巴细胞亚群的变化及其临床意义[J].广西医学,2013,35(8):1021-1022.[12]陈霄峰,梁小裕,郏雪萍,等.成人特发性血小板减少性紫癜患者细胞免疫功能的变化及临床意义[J].浙江实用医学,2013,18(1):29-30,67.[13]冯建军,杨林花,陈剑芳,等.ITP血小板特异性抗体和T淋巴细胞亚群及NK细胞变化的意义探讨[J].临床血液学杂志,2009,22(1):27-29,32.[14]张春梅,朱宁喜,滕清良.特发性血小板减少性紫癜患者免疫功能的研究[J].泰山医学院学报,2008,29(3):186-188.[15]Chen Z,Qu W,Wang HQ,et al.Relationship of Peripheral Blood IL-37 Expression with T Lymphocytes Subsets and NK Cells in Patients with Primary Immune Thrombocytopenia[J].Journal of Experimental Hematology,2019,27(4):1201-1207.[16]Xu J,Wang G,Tan S,et al.The clinical effect of Prednisone in combination with Mycophenolate mofetil on idiopathic thrombocytopenic purpura (ITP) and its influence on the level of peripheral blood T lymphocytes and NK lymphocytes[J].Saudi J Biol Sci,2019,26(8):2108-2112.[17]El-Rashedi FH,El-Hawy MA,Helwa MA,et al.Study of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura[J].Hematol Oncol Stem Cell Ther,2017,10(1):8-14.[18]马文典,张坤,王弘,等.急性免疫性血小板减少症患儿NK细胞、NK样T细胞数量变化及槐杞黄联合糖皮质激素疗效探讨[J].实用药物与临床,2017,20(4):386-389.[19]Talaat RM,Elmaghraby AM,Barakat SS,et al.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP) [J].Clin Exp Immunol,2014,176(2):291-300.[20]Ebbo M,Audonnet S,Grados A,et al.NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia[J].Clin Immunol,2017,177:18-28.[21]Kucuksezer UC,Aktas Cetin E,Esen F,et al.The Role of Natural Killer Cells in Autoimmune Diseases[J].Front Immunol,2021,12:622306.[22]Zahran AM,Abdel-Rahim MH,Elsayh KI,et al.Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression[J].Arch Immunol Ther Exp (Warsz),2019,67(3):161-169.[23]Fathollahi A,Samimi LN,Akhlaghi M,et al.The role of NK cells in rheumatoid arthritis[J].Inflamm Res,2021,70(10-12):1063-1073.[24]Poggi A,Benelli R,Venè R,et al.Human Gut-Associated Natural Killer Cells in Health and Disease[J].Front Immunol,2019,10:961.[25]Ruder J,Rex J,Obahor S,et al.NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis[J].Front Immunol,2021,12:794077. [26]Eggenhuizen PJ,Ng BH,Ooi JD.Treg Enhancing Therapies to Treat Autoimmune Diseases[J].Int J Mol Sci,2020,21(19):7015.[27]Zufferey A,Kapur R,Semple JW.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)[J].J Clin Med,2017,6(2):16.[28]Zhong H,Bussel J,Yazdanbakhsh K.In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia[J].Br J Haematol,2015,168(2):274-283.[29]Kostic M,Zivkovic N,Cvetanovic A,et al.CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia[J].Cell Immunol,2020,351:104096.[30]Talaat RM,Elmaghraby AM,Barakat SS,et al.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)[J].Clin Exp Immunol,2014,176(2):291-300.[31]Johansson U,Macey MG,Kenny D,et al.The role of natural killer T (NKT) cells in immune thrombocytopenia: is strong in vitro NKT cell activity related to the development of remission?[J].Br J Haematol,2005,129(4):564-565.
相似文献/References:
[1]赵长海,任秀敏,杨晓丹,等.腔镜辅助近端胃癌根治术对近端胃癌患者NK细胞以及T淋巴细胞影响分析[J].医学信息,2020,33(08):110.[doi:10.3969/j.issn.1006-1959.2020.08.034]
ZHAO Chang-hai,REN Xiu-min,YANG Xiao-dan,et al.Effect of Endoscopic Assisted Radical Gastrectomy on NK Cells and T Lymphocytes[J].Journal of Medical Information,2020,33(01):110.[doi:10.3969/j.issn.1006-1959.2020.08.034]
[2]户乃丽,徐晓雪,邹林樾,等.FACSAriaⅢ流式细胞仪分选小鼠肺脏自然杀伤细胞方法的建立与评价[J].医学信息,2021,34(15):115.[doi:10.3969/j.issn.1006-1959.2021.15.030]
HU Nai-li,XU Xiao-xue,ZOU Lin-yue,et al.Establishment and Evaluation of A Method for Sorting Mouse Lung Natural Killer Cells by FACSAria Ⅲ Flow Cytometer[J].Journal of Medical Information,2021,34(01):115.[doi:10.3969/j.issn.1006-1959.2021.15.030]
[3]伏开新.肿瘤患者外周血T淋巴细胞亚群及NK细胞比例检测的价值[J].医学信息,2021,34(20):125.[doi:10.3969/j.issn.1006-1959.2021.20.032]
FU Kai-xin.The Value of Peripheral Blood T Lymphocyte Subsets and NK Cell Ratio in Tumor Patients[J].Journal of Medical Information,2021,34(01):125.[doi:10.3969/j.issn.1006-1959.2021.20.032]
[4]武文琦,闫振宇.原发免疫性血小板减少症免疫机制及免疫治疗的研究进展[J].医学信息,2023,36(13):177.[doi:10.3969/j.issn.1006-1959.2023.13.040]
WU Wen-qi,YAN Zhen-yu.Research Progress on Immune Mechanism and Immunotherapy of Primary Immune Thrombocytopenia[J].Journal of Medical Information,2023,36(01):177.[doi:10.3969/j.issn.1006-1959.2023.13.040]
[5]郑程莉,昌 菁,朱文伟.基于数据挖掘的中医药治疗儿童原发免疫性血小板减少症的临床用药规律研究[J].医学信息,2025,38(08):1.[doi:10.3969/j.issn.1006-1959.2025.08.001]
ZHENG Chengli,CHANG Jing,ZHU Wenwei.Study on the Clinical Medication Rules of Traditional Chinese Medicine in the Treatment of Primary Immune Thrombocytopenia in Children Based on Data Mining[J].Journal of Medical Information,2025,38(01):1.[doi:10.3969/j.issn.1006-1959.2025.08.001]